Stratec SE (SBS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Stratec SE (SBS) has a cash flow conversion efficiency ratio of 0.004x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.00 Million ≈ $1.17 Million USD) by net assets (€237.32 Million ≈ $277.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Stratec SE to measure how much of total assets are equity-financed.
Stratec SE - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Stratec SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Stratec SE (SBS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Stratec SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stratec SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Palma Serasih PT
JK:PSGO
|
0.078x |
|
Compagnie Du Mont-Blanc
PA:MLCMB
|
0.078x |
|
Smurfit Westrock Plc
LSE:SWR
|
0.011x |
|
Kimteks Poliuretan Sanayi ve Ticaret AS
IS:KMPUR
|
0.157x |
|
Imperial Petroleum Inc
NASDAQ:IMPP
|
0.045x |
|
Bank Nationalnobu Tbk
JK:NOBU
|
-0.108x |
|
Willy Food
TA:WLFD
|
0.028x |
|
TROOPS Inc
NASDAQ:TROO
|
-0.081x |
Annual Cash Flow Conversion Efficiency for Stratec SE (2002–2025)
The table below shows the annual cash flow conversion efficiency of Stratec SE from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Stratec SE (SBS) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €237.32 Million ≈ $277.45 Million |
€-433.00K ≈ $-506.22K |
-0.002x | -100.91% |
| 2024-12-31 | €242.53 Million ≈ $283.55 Million |
€48.71 Million ≈ $56.95 Million |
0.201x | +141.25% |
| 2023-12-31 | €233.33 Million ≈ $272.78 Million |
€19.43 Million ≈ $22.71 Million |
0.083x | +82.38% |
| 2022-12-31 | €225.18 Million ≈ $263.26 Million |
€10.28 Million ≈ $12.02 Million |
0.046x | -85.20% |
| 2021-12-31 | €205.76 Million ≈ $240.55 Million |
€63.47 Million ≈ $74.21 Million |
0.308x | +67.12% |
| 2020-12-31 | €172.54 Million ≈ $201.72 Million |
€31.85 Million ≈ $37.23 Million |
0.185x | +38.04% |
| 2019-12-31 | €159.01 Million ≈ $185.90 Million |
€21.26 Million ≈ $24.86 Million |
0.134x | +70.31% |
| 2018-12-31 | €152.20 Million ≈ $177.94 Million |
€11.95 Million ≈ $13.97 Million |
0.079x | -58.67% |
| 2017-12-31 | €157.84 Million ≈ $184.53 Million |
€29.98 Million ≈ $35.05 Million |
0.190x | +67.93% |
| 2016-12-31 | €143.72 Million ≈ $168.02 Million |
€16.26 Million ≈ $19.00 Million |
0.113x | -43.40% |
| 2015-12-31 | €130.28 Million ≈ $152.31 Million |
€26.03 Million ≈ $30.44 Million |
0.200x | -43.67% |
| 2014-12-31 | €112.05 Million ≈ $131.00 Million |
€39.75 Million ≈ $46.47 Million |
0.355x | +44.63% |
| 2013-12-31 | €97.18 Million ≈ $113.61 Million |
€23.84 Million ≈ $27.87 Million |
0.245x | +729.52% |
| 2012-12-31 | €91.98 Million ≈ $107.54 Million |
€2.72 Million ≈ $3.18 Million |
0.030x | -77.01% |
| 2011-12-31 | €83.23 Million ≈ $97.31 Million |
€10.71 Million ≈ $12.52 Million |
0.129x | +538.58% |
| 2010-12-31 | €71.88 Million ≈ $84.03 Million |
€1.45 Million ≈ $1.69 Million |
0.020x | -89.02% |
| 2009-12-31 | €59.29 Million ≈ $69.31 Million |
€10.88 Million ≈ $12.72 Million |
0.183x | +95.22% |
| 2008-12-31 | €49.90 Million ≈ $58.34 Million |
€4.69 Million ≈ $5.48 Million |
0.094x | -52.28% |
| 2007-12-31 | €48.58 Million ≈ $56.79 Million |
€9.57 Million ≈ $11.19 Million |
0.197x | -10.44% |
| 2006-12-31 | €40.13 Million ≈ $46.92 Million |
€8.83 Million ≈ $10.32 Million |
0.220x | +430.06% |
| 2005-12-31 | €31.52 Million ≈ $36.85 Million |
€1.31 Million ≈ $1.53 Million |
0.041x | -73.32% |
| 2004-12-31 | €15.47 Million ≈ $18.08 Million |
€2.41 Million ≈ $2.81 Million |
0.156x | +384.79% |
| 2003-12-31 | €12.87 Million ≈ $15.05 Million |
€413.00K ≈ $482.84K |
0.032x | -99.98% |
| 2002-12-31 | €11.17K ≈ $13.06K |
€1.73 Million ≈ $2.03 Million |
155.162x | -- |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and softwar… Read more